microdosing glp-1 side effects for Hashimoto's: Evidence, Risks and NHS Guidance – Bolt Pharmacy GLP-1 medications are changing how

- Yagishita et al., 2019, provide an excellent review assessing the current state of knowledge on the relationships between formulation (e.g., plants, sprouts, drinks, supplements), bioavailability and efficacy, and the doses of glucoraphanin and/or sulforaphane that have been used in preclinical and clinical studies, paying particular attention to better integration of animal models and clinical studies, particularly with regard to dose selection and route of administration [126]

As an electrophile, sulforaphane directly interacts with protein thiols forming thionoacyl adducts

Liver injury Liver protective effect of 2-AR (mechanism using DEX as an example) Hepatocellular injury is driven by reactive oxygen species, pro-fibrotic mediators, hepatic stellate cell (HSC) activation, and myofibroblast effects, leading to tissue inflammation and disease progression 56

Headache Pain 46 PuccinelliE.GervasiP

Zhang J, Zhang F, Zhao C, Xu Q, Liang C, Yang Y, et al

Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., Sio, I